Xenglu Lin 25+5mg Tablet

Description

When metformin and/or sulphonylurea (SU) and monotherapy of either of Empagliflozin and Linagliptin do not provide adequate glycemic control, Empagliflozin + Linagliptin is indicated as an adjuvant to diet and exercise in adults with type 2 diabetes mellitus aged 18 years and older. – when already receiving treatment with the free combination of Empagliflozin and Linagliptin. Adults with established cardiovascular disease and type 2 diabetes mellitus should take empagliflozin to lower their risk of cardiovascular death.